Effects of High Dose Methotrexate and Delayed Elimination on Myelotoxicity Progression in Children with Acute Lymphoblastic Leukemia

Background and study aim: Methotrexate (MTX) as an antineoplastic agent inhibits dihydrofolate reductase. The frequency of high dose methotrexate (HDMTX) associated toxicity is variable. In this study we investigate the frequency of myelosuppression following 5 and 9 days of HDMTX infusion and MTX d...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Hassan El Fayoumi, Usama El-Safy, Manar Fathy, Omar El-Azzazy
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Zagazig University, Faculty of Medicine, Endemic and Tropical Medicine Department 2017-03-01
סדרה:	Afro-Egyptian Journal of Infectious and Endemic Diseases
נושאים:	HDMDX ALL Myelosuppresion Blood count
גישה מקוונת:	https://aeji.journals.ekb.eg/article_8993_83abd9b8c54cc998d929f2199ba7069f.pdf
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!